MedPath

Incidence of postoperative nausea and vomiting after remimazolam or propofol anesthesia

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0008825
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
84
Inclusion Criteria

Non-smoking adult female patients aged 19 years or older undergoing elective partial mastectomy under general anesthesia at Yonsei Cancer Center

Exclusion Criteria

1. Patients with a history of hypersensitivity or allergy to propofol or remimazolam
2. Patients who are contraindicated for propofol total intravenous anesthesia
3. Patients who are contraindicated for Remimazolam anesthesia
4. Pregnant women, patients with ASA PS-III abnormality

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of postoperative nausea within 24 hours after completion of surgery
Secondary Outcome Measures
NameTimeMethod
Incidence of postoperative vomiting within 24 hours after completion of surgery;Severity of postoperative nausea within 24 hours after completion of surgery;Dose of rescue analgesics administered up to 24 hours after surgery;Dose of rescue antiemetics administered up to 24 hours after surgery;Pain score in the recovery room immediately after surgery;Satisfaction with pain control after postoperative 24 hours;Incidence of intraoperative hypotention
© Copyright 2025. All Rights Reserved by MedPath